Eloxx Pharmaceuticals Reports First Quarter 2018 Financial And Operating Results And Provides Business Update | Latest News RSS feed

Eloxx Pharmaceuticals Reports First Quarter 2018 Financial And Operating Results And Provides Business Update - Latest News


Eloxx Pharmaceuticals Reports Second Quarter 2018 Financial and Operating Results and Provides Business Update

Aug. 07, 2018 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals ... today reported its financial results for the three and six months ended June 30, 2018 and provided a business update. “We are pleased to hav... read more

Eloxx Pharmaceuticals' (ELOX) CEO Robert Ward on Q2 2018 Results - Earnings Call Transcript

Thank you, Sara, and welcome and thank you to joining us – those of you joining us this afternoon for a review of Eloxx Pharmaceuticals’ Second Quarter 2018 Financial Results and Business Update ... t... read more

Abbott Laboratories: Abbott Reports Third-Quarter 2018 Results

The table above provides additional ... Non-GAAP Reconciliation of Financial Information From Continuing Operations.' a) Acquisition-related expenses include costs for legal, accounting, tax, and othe... read more

Looking for another news?


Celgene Reports First Quarter 2017 Operating and Financial Results

SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ:CELG) reported net product sales of $2,950 million for the first quarter of ... from our adjusted financial results that are either non-cash ... read more


Acerus to Report Second Quarter 2018 Financial Results and Host Investor Call

TORONTO — Acerus Pharmaceuticals Corporation (TSX:ASP) will announce its second quarter 2018 financial and operating results on Monday August 13, 2018 before market opens. The company will host a conf... read more

Viking Therapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update

Markets Insider and Business Insider Editorial Teams were not involved in the creation of this post. SEE ALSO: Snap is an 'attractive candidate to go private' if management can't reverse its usage tre... read more

Juniper Pharmaceuticals Reports First Quarter 2018 Financial and Operating Results

First Quarter and Recent Corporate Highlights First Quarter Financial Results "Growth in our core businesses has continued into 2018 ... Pharmaceuticals' ability to manage operating expenses and/or ob... read more

Eloxx Pharmaceuticals Reports First Quarter 2018 Financial and Operating Results and Provides Business Update

On April 30, 2018, the Company closed an underwritten public offering of 5,899,500 shares of common stock at the public offering price of $9.75, raising net proceeds of $53.4 million, after deducting ... read more

Vertex Pharmaceuticals : Reports First-Quarter 2018 Financial Results

The company adopted ASU No. 2016-01, Recognition and Measurement of Financial Assets and Financial Liabilities ... related to stock-based compensation of $21.9 million in the first quarter of 2018 and ... read more

Prometic Reports Second Quarter 2018 Financial Results and Highlights

The Corporation also provides access to its proprietary bioseparation technologies to enable pharmaceutical ... reports-second-quarter-2018-financial-results-and-highlights-300697190.html SOURCE ProMe... read more

Eloxx Pharmaceuticals' (ELOX) CEO Bob Ward on Q1 2018 Results - Earnings Call Transcript

Welcome and thank you for joining us this afternoon for review of Eloxx Pharmaceuticals first quarter 2018 financial results and business update. Joining me this afternoon ... section in our most rece... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us